Health AI Register Logo
ProductsCompaniesNewsContact

Key Features

  • Flow quantification
  • Ischemia quantification
  • Perfusion quantification
  • Segmentation
  • Volume quantification
  • Wall motion abnormality dectection

General Information

Product name

cvi42 for Cardiac MRI

Subspeciality

Cardiac

Modality

MR

Disease targeted

Heart failure, ischemic heart disease, myocardial infarction, cardiomyopathies, myocarditis, valvular heart disease, cardiac mass, pericardial disease, atrial fibrillation

Main task

Not specified

Technical Specifications

Population

Not specified

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register
FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

11-2008

AI Platforms

Bayer Pharmaceuticals, Siemens Healthineers

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Evidence & Research

No research papers or evidence available for this product.

Source: public | First published: Jan 10, 2020 | Last updated: Jul 11, 2025